Probiotics, Prebiotics, Synbiotics and the Gut-Brain Axis in Precision Health

Authors: Sikarwar, Mukesh Singh; Siddiqui, Zeba; Rathi, Vaibhav Kumar

Source journal: Advances in experimental medicine and biology (2026-01-01)

DOI: 10.1007/978-981-92-0010-8_3

Abstract

The gastrointestinal system synthesizes a considerable proportion of the body's neurotransmitters and neuromodulators and is consequently increasingly acknowledged as the "second brain." Advances in high-throughput sequencing technology following the Human Genome Project have considerably expanded understanding of the gut microbiome, igniting increasing interest in microbiota-based medicinal approaches. Probiotics, defined as live microorganisms offering health benefits when provided in suitable doses, have proven potential in the management of chronic inflammatory and immune-mediated illnesses through immunomodulatory and barrier-protective pathways. The therapeutic efficacy of probiotics is strain-specific and influenced by dosage, host physiology, and environmental factors; consequently, strain selection prioritizes functional attributes such as gastrointestinal survivability, adhesion to intestinal epithelium, modulation of resident microbiota, and antimicrobial activity. Despite promising clinical and preclinical evidence, comprehensive elucidation of the systemic effects of probiotics and identification of novel symbiotic strains remain critical research priorities, underscoring the need for interdisciplinary collaboration between pharmacologists and microbiologists.Another highly integral aspect of nutrition and medical research involves prebiotics. Prebiotics are defined as selectively fermentable substances that promote the activity and number of beneficial microbes in the gastrointestinal region. Oligosaccharides and inulin are examples that add to the betterment of metabolic homeostasis and immune system functioning. The rising consumer education and innovation have led to large-scale expansion in the prebiotics industry, which strengthens the connection between microbiology, nutrition, and health economics.Synbiotics that combine both probiotics and prebiotics represent a cutting-edge strategy that can enhance the resistance and stability of gut microbiota, especially in the gut-brain axis (GBA) microbiota network. New multiomics approaches have revealed the intricate relationships that exist between the microbiota and the host that modulate neuropathological, metabolic, and immunological outcomes. There is a great variation in the microbial populations and corresponding metabolic products among different human subjects that clearly reveals the need to develop microbiota-targeting therapies.

Read the full text

Related topics

Related open access articles

Abstract and bibliographic data from PubMed (U.S. National Library of Medicine). Copyright of the abstract belongs to the original publisher or authors.